AR107426A1 - DERIVADOS DE N-INDEN-AMIDA COMO MODULADORES DEL mGluR7 - Google Patents
DERIVADOS DE N-INDEN-AMIDA COMO MODULADORES DEL mGluR7Info
- Publication number
- AR107426A1 AR107426A1 ARP170100186A ARP170100186A AR107426A1 AR 107426 A1 AR107426 A1 AR 107426A1 AR P170100186 A ARP170100186 A AR P170100186A AR P170100186 A ARP170100186 A AR P170100186A AR 107426 A1 AR107426 A1 AR 107426A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- heterocyclic ring
- halogen
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/41—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/23—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/30—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/08—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epoxy Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en la terapia de trastornos auditivos y del SNC. Reivindicación 1: Un compuesto de fórmula (1) donde R¹ representa hidroxilo, -CH₂OH, ciano, -SO₂R¹ᵃ, -(CH₂)ₘ-(O)ₙ-R⁵ o (CH₂)ₚNR⁶R⁷; m es 0 ó 1; n es 0 ó 1; p es 0 ó 1; R¹ᵃ representa alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆; cada uno de R² y R³ representa independientemente hidrógeno, halógeno, fluorometilo, difluorometilo, trifluorometilo, metoxi, fluorometoxi, difluorometoxi o trifluorometoxi; cualquier R⁴ᵃ representa (X)ₜ-(CH₂)ᵛ-R¹⁶ o -CH₂O-R¹⁷ y R⁴ᵇ representa hidrógeno, metilo o flúor, o R⁴ᵃ y R⁴ᵇ, junto con el átomo de carbono al cual se acoplan, forman un anillo heterocíclico o carbocíclico saturado de 3 a 6 miembros, donde el anillo heterocíclico comprende al menos un heteroátomo anular que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo carbocíclico o heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno, oxo, alquilo C₁₋₃, alcoxi C₁₋₃, amino, metilamino, dimetilamino y haloalquilo C₁₋₃; R⁵ representa un grupo cicloalquilo C₃₋₆, un anillo heterocíclico de 4 a 6 miembros que contiene un heteroátomo anular individual que es un átomo de nitrógeno donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente seleccionado de halógeno, alquilo C₁₋₃ y haloalquilo C₁₋₃ o un grupo alquilo C₁₋₆ que no está sustituido o está sustituido con al menos un sustituyente seleccionado de cicloalquilo C₃₋₆, NR²²R²³ y un anillo heterocíclico saturado de 4 a 6 miembros que comprende al menos un heteroátomo anular que se selecciona de átomos de nitrógeno y oxígeno, donde dicho anillo heterocíclico no está sustituido o está sustituido con halógeno; cada uno de R⁶ y R⁷ representa independientemente hidrógeno, -(CH₂)q-R⁸, -SO₂R⁹, alquilo C₁₋₆, alquilcarbonilo C₁₋₆, cicloalquilcarbonilo C₃₋₆ o alcoxicarbonilo C₁₋₆, donde cada uno de los restos alquilo, cicloalquilo o alcoxi en los últimos cuatro sustituyentes no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno, alcoxi C₁₋₄ y -NR¹⁰R¹¹, o R⁶ y R⁷, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado o no saturado de 4 a 7 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de nitrógeno, oxígeno y azufre, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno, ciano, alquilo C₁₋₆, cicloalquilo C₃₋₆, cicloalquilmetilo C₃₋₆, haloalquilo C₁₋₆, alcoxi C₁₋₆, cicloalquiloxi C₃₋₆, cicloalquilmetiloxi C₃₋₆ y -NR¹²R¹³; q es 0, 1 ó 2; R⁸ representa un anillo carbocíclico o heterocíclico saturado o no saturado de 3 a 6 miembros donde el anillo heterocíclico comprende de 1 a 4 heteroátomos anulares que se seleccionan independientemente de nitrógeno, oxígeno y azufre, donde el anillo carbocíclico o heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno, ciano, alquilo C₁₋₆, cicloalquilo C₃₋₆, cicloalquilmetilo C₃₋₆, haloalquilo C₁₋₆, alcoxi C₁₋₆, cicloalquiloxi C₃₋₆, cicloalquilmetiloxi C₃₋₆ y -NR¹⁴R¹⁵; R⁹ representa alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, cada uno de los cuales no está sustituido o está sustituido con al menos un átomo de halógeno; cada uno de R¹⁰ y R¹¹ representa independientemente hidrógeno, alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, o R¹⁰ y R¹¹, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado de 4 a 6 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alquilo C₁₋₃; cada uno de R¹² y R¹³ representa independientemente hidrógeno, alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, o R¹² y R¹³, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado de 4 a 6 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alquilo C₁₋₃; cada uno de R¹⁴ y R¹⁵ representa independientemente hidrógeno, alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, o R¹⁴ y R¹⁵, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado de 4 a 6 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alquilo C₁₋₃; t es 0 ó 1; v es 0, 1 ó 2; R¹⁶ representa -R¹⁷, -NR¹⁸R¹⁹ o un anillo heterocíclico saturado o no saturado de 4 a 6 miembros que comprende de 1 a 4 heteroátomos anulares que se seleccionan independientemente de nitrógeno, oxígeno y azufre, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente seleccionado de oxo, halógeno, ciano, fluorometoxi, difluorometoxi, trifluorometoxi, alquilo C₁₋₆, alcoxi C₁₋₆ y haloalquilo C₁₋₆; X es O, NH, -NHC(O)-, -NHC(O)O-, -C(O)NH-, -NHSO₂- o -SO₂NH-, siempre que cuando X sea O, NH, -C(O)NH- o -SO₂NH- y R¹⁶ represente -NR¹⁸R¹⁹, v sea 2; R¹⁷ representa alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, cada uno de los cuales no está sustituido o está sustituido con al menos un sustituyente que se selecciona de hidroxilo, halógeno y -NR²⁰R²¹; cada uno de R¹⁸ y R¹⁹ representa independientemente hidrógeno, alquilo C₁₋₆, alquilcarbonilo C₁₋₆, cicloalquilcarbonilo C₃₋₆, alquilsulfonilo C₁₋₆ o cicloalquilsulfonilo C₃₋₆, donde cada uno de los restos alquilo o cicloalquilo en los últimos cinco sustituyentes no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alcoxi C₁₋₄, o R¹⁸ y R¹⁹, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado de 4 a 6 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alquilo C₁₋₃; cada uno de R²⁰ y R²¹ representa independientemente hidrógeno, alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, o R²⁰ y R²¹, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado de 4 a 6 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alquilo C₁₋₃; y cada uno de R²² y R²³ representa independientemente hidrógeno, alquilo C₁₋₆, cicloalquilo C₃₋₆ o cicloalquilmetilo C₃₋₆, o R²² y R²³, junto con el átomo de nitrógeno al cual se acoplan, forman un anillo heterocíclico saturado de 4 a 6 miembros que comprende opcionalmente un heteroátomo anular adicional que se selecciona de átomos de nitrógeno y oxígeno, donde el anillo heterocíclico no está sustituido o está sustituido con al menos un sustituyente que se selecciona de halógeno y alquilo C₁₋₃; siempre que el compuesto de fórmula (1) no sea N-[(1S,2S)-1-amino-2,3-dihidro-1H-inden-2-il]-1-(4-fluorofenil)ciclopropano-1-carboxamida; o una sal farmacéuticamente aceptable de este.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1601301.3A GB201601301D0 (en) | 2016-01-25 | 2016-01-25 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR107426A1 true AR107426A1 (es) | 2018-04-25 |
Family
ID=55534857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170100186A AR107426A1 (es) | 2016-01-25 | 2017-01-25 | DERIVADOS DE N-INDEN-AMIDA COMO MODULADORES DEL mGluR7 |
Country Status (25)
Country | Link |
---|---|
US (1) | US20190031599A1 (es) |
EP (1) | EP3408256A1 (es) |
JP (1) | JP2019508390A (es) |
KR (1) | KR20180108600A (es) |
CN (1) | CN108602760A (es) |
AR (1) | AR107426A1 (es) |
AU (1) | AU2017210803A1 (es) |
BR (1) | BR112018015247A2 (es) |
CA (1) | CA3012443A1 (es) |
CL (1) | CL2018002010A1 (es) |
CO (1) | CO2018007610A2 (es) |
EA (1) | EA201891680A1 (es) |
EC (1) | ECSP18056196A (es) |
GB (1) | GB201601301D0 (es) |
HK (1) | HK1257091A1 (es) |
MA (1) | MA43922A (es) |
MX (1) | MX2018009078A (es) |
PE (1) | PE20181333A1 (es) |
PH (1) | PH12018501563A1 (es) |
SG (1) | SG11201804899YA (es) |
TN (1) | TN2018000175A1 (es) |
TW (1) | TW201733977A (es) |
UY (1) | UY37084A (es) |
WO (1) | WO2017131221A1 (es) |
ZA (1) | ZA201803520B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3366683A1 (en) | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
CN115667212A (zh) | 2020-05-29 | 2023-01-31 | 富士胶片富山化学株式会社 | 高纯度的n-(5-甲氧基-2-苯氧基苯基)甲磺酰胺及其制造方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK626889A (da) * | 1988-12-16 | 1990-06-17 | Roussel Uclaf | Indanderivater, deres fremstilling samt laegemidler med indhold deraf |
CA2138788A1 (en) * | 1992-06-22 | 1994-01-06 | Dietrich Arndts | Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
DE4220353A1 (de) * | 1992-06-22 | 1993-12-23 | Boehringer Ingelheim Kg | Verwendung carbocyclisch und heterocyclisch annelierter Dihydropyridine als Mittel mit antiproliferativer Wirkung |
EP1009758B1 (en) * | 1997-08-29 | 2005-06-01 | Tularik Limited | Meta-benzamidine derivatives as serine protease inhibitors |
JP2003502314A (ja) * | 1999-06-14 | 2003-01-21 | イーライ・リリー・アンド・カンパニー | 化合物 |
EP1194400A1 (en) * | 1999-06-30 | 2002-04-10 | Prescient Neuropharma Inc. | 2-aminoindane analogs |
EP1193248A1 (en) * | 2000-09-30 | 2002-04-03 | Aventis Pharma Deutschland GmbH | Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
WO2002051232A2 (en) * | 2000-12-27 | 2002-07-04 | Actelion Pharmaceuticals Ltd. | Novel benzazepines and related heterocyclic derivatives |
TWI243164B (en) * | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
PE20020856A1 (es) * | 2001-02-13 | 2002-11-11 | Aventis Pharma Gmbh | 1,2,3,4-tetrahidronaftil aminas aciladas |
DE10108307A1 (de) * | 2001-02-21 | 2002-08-29 | Gruenenthal Gmbh | Substituierte Propan-1,3-diamin-Derivate |
JPWO2002102807A1 (ja) * | 2001-06-14 | 2004-09-30 | 萬有製薬株式会社 | 新規イソキサゾロピリドン誘導体及びその用途 |
TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
EP1388342A1 (en) * | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
EP1477167A1 (en) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
EP1529525A1 (en) * | 2003-11-06 | 2005-05-11 | Aventis Pharma Deutschland GmbH | ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases |
DK1751131T3 (da) * | 2004-03-10 | 2009-03-16 | Janssen Pharmaceutica Nv | MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocykler |
NZ552979A (en) * | 2004-08-09 | 2010-02-26 | Glaxo Group Ltd | Indane and tetralin derivatives which potentiate glutamate receptor and uses thereof in medicine |
CN101248046A (zh) * | 2005-07-11 | 2008-08-20 | 德福根有限公司 | 作为激酶抑制剂的酰胺衍生物 |
US8324250B2 (en) * | 2009-03-19 | 2012-12-04 | Hoffmann-La Roche Inc. | Piperidine derivatives as NK3 receptor antagonists |
-
2016
- 2016-01-25 GB GBGB1601301.3A patent/GB201601301D0/en not_active Ceased
-
2017
- 2017-01-24 CA CA3012443A patent/CA3012443A1/en not_active Abandoned
- 2017-01-24 MX MX2018009078A patent/MX2018009078A/es unknown
- 2017-01-24 EA EA201891680A patent/EA201891680A1/ru unknown
- 2017-01-24 JP JP2018538807A patent/JP2019508390A/ja active Pending
- 2017-01-24 SG SG11201804899YA patent/SG11201804899YA/en unknown
- 2017-01-24 TN TNP/2018/000175A patent/TN2018000175A1/en unknown
- 2017-01-24 EP EP17707970.4A patent/EP3408256A1/en not_active Withdrawn
- 2017-01-24 WO PCT/JP2017/003078 patent/WO2017131221A1/en active Application Filing
- 2017-01-24 KR KR1020187020895A patent/KR20180108600A/ko unknown
- 2017-01-24 CN CN201780008229.1A patent/CN108602760A/zh active Pending
- 2017-01-24 PE PE2018001311A patent/PE20181333A1/es unknown
- 2017-01-24 AU AU2017210803A patent/AU2017210803A1/en not_active Abandoned
- 2017-01-24 BR BR112018015247A patent/BR112018015247A2/pt not_active Application Discontinuation
- 2017-01-24 US US16/072,296 patent/US20190031599A1/en not_active Abandoned
- 2017-01-24 TW TW106102593A patent/TW201733977A/zh unknown
- 2017-01-24 UY UY0001037084A patent/UY37084A/es not_active Application Discontinuation
- 2017-01-24 MA MA043922A patent/MA43922A/fr unknown
- 2017-01-25 AR ARP170100186A patent/AR107426A1/es unknown
-
2018
- 2018-05-28 ZA ZA2018/03520A patent/ZA201803520B/en unknown
- 2018-07-20 PH PH12018501563A patent/PH12018501563A1/en unknown
- 2018-07-23 CO CONC2018/0007610A patent/CO2018007610A2/es unknown
- 2018-07-24 CL CL2018002010A patent/CL2018002010A1/es unknown
- 2018-07-25 EC ECSENADI201856196A patent/ECSP18056196A/es unknown
- 2018-12-20 HK HK18116340.3A patent/HK1257091A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
UY37084A (es) | 2017-08-31 |
EA201891680A1 (ru) | 2019-01-31 |
CN108602760A (zh) | 2018-09-28 |
GB201601301D0 (en) | 2016-03-09 |
ZA201803520B (en) | 2019-03-27 |
AU2017210803A1 (en) | 2018-07-19 |
PE20181333A1 (es) | 2018-08-20 |
CO2018007610A2 (es) | 2018-07-31 |
JP2019508390A (ja) | 2019-03-28 |
CA3012443A1 (en) | 2017-08-03 |
BR112018015247A2 (pt) | 2018-12-18 |
MX2018009078A (es) | 2018-11-09 |
PH12018501563A1 (en) | 2019-05-15 |
US20190031599A1 (en) | 2019-01-31 |
HK1257091A1 (zh) | 2019-10-11 |
SG11201804899YA (en) | 2018-07-30 |
KR20180108600A (ko) | 2018-10-04 |
TW201733977A (zh) | 2017-10-01 |
ECSP18056196A (es) | 2018-08-31 |
MA43922A (fr) | 2018-12-05 |
EP3408256A1 (en) | 2018-12-05 |
CL2018002010A1 (es) | 2019-03-15 |
TN2018000175A1 (en) | 2019-10-04 |
WO2017131221A1 (en) | 2017-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR106301A1 (es) | Composiciones de pirrolpirimidina como inhibidores de quinasas | |
AR110922A1 (es) | Compuestos inhibidores del vih | |
AR126406A2 (es) | Compuestos de tetrazolinona y su uso | |
AR112529A1 (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos en el tratamiento de diversos tipos de cáncer | |
AR099228A1 (es) | Inhibidores macrocíclicos de fxia que tienen grupos heterocíclicos | |
AR093364A1 (es) | Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso | |
AR100886A1 (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
AR101189A1 (es) | Heterociclos nitrogenados antiproliferativos y sus métodos de uso | |
AR095198A1 (es) | Derivados de triazolona de piridinilo y piridinilo fusionado | |
AR091981A1 (es) | Dihidropiridona p1 como inhibidores del factor xia | |
AR101208A1 (es) | Espirocicloheptanos como inhibidores de rock | |
AR104513A1 (es) | Derivados de ciclohexano sustituidos con amidas como inhibidores de tnks1 y/o tnks2 | |
AR092108A1 (es) | Piridazina 1,4 disustituida, analogos de la misma y metodos para tratar las enfermedades relacionadas con deficiencia del smn | |
AR088423A1 (es) | Ligadores p1 ciclicos como inhibidores del factor xia | |
AR089143A1 (es) | Triazolopiridinas sustituidas con actividad inhibidora de ttk | |
AR112804A1 (es) | Compuestos de bisamida que activan el sarcómero y sus usos | |
AR094550A1 (es) | Inhibidores de btk | |
AR098492A1 (es) | Derivados de purina | |
AR096846A1 (es) | Dihidroquinoxalinonas y dihidropiridopirazinonas modificadas como inhibidores de la proteína bet | |
AR107054A1 (es) | DERIVADOS DE ISOINDOL Y COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR RORg Y RORgt | |
AR097403A1 (es) | Derivados de benzamida como antagonistas de lpar1 y/o lpar5 y un proceso para su preparación | |
AR097754A1 (es) | Derivados sustituidos de fenilalanina | |
AR112086A1 (es) | Compuestos heteroaromáticos como inhibidores de vanina | |
AR098436A1 (es) | Compuestos tricíclicos de piperidina | |
AR099690A1 (es) | Ureas asimétricas p-sustituidas como moduladoras de la actividad de ghrelina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |